Head and neck cancers

This trial is comparing BT113 and pembrolizumab to pembrolizumab alone, for squamous cell head and neck cancer.

This trial is looking at a drug called UCB4594 by itself and in combination with other treatments for solid cancers that have spread (advanced cancer).

This study is looking at the experiences of people who wear a mask during their radiotherapy for head and neck cancer.

This trial is looking at the best dose of HTL0039732 for solid tumours that have spread to another part of the body.

This study is looking at new drug called alomfilimab (KY1044) by itself and in combination with atezolizumab for advanced cancers.

This study is looking at a drug called INCB106385 by itself or with another immunotherapy called retifanlimab (INCMGA00012) for some advanced solid cancers.

This trial is looking at whether a programme of exercises before treatment can help people with their eating, drinking and swallowing after treatment.

This trial is looking at adding certain targeted drugs to radiotherapy for head and neck cancer.